Siemens

Stratec Molecular has been awarded

Title: Process for determining the concentration of nucleic acids.
Patent Number: 8,715,924
Filed: June 13, 2007

Siemens has been awarded

ALBUQUERQUE, NM (GenomeWeb News) — Long-read sequencing can enable researchers to not only detect what drug-resistance mutations are present in someone with HIV, but also whether those mutations are present in one strain or spread across multiple strains of the virus circulating in that patient,

NEW YORK (GenomeWeb News) – Siemens Healthcare Diagnostics today said that it has signed a master collaboration agreement with Pfizer for the development of companion diagnostics for certain undisclosed therapeutic products in the drug giant's pipeline.

RainDance Technologies this week announced it has added a high-precision chromosomal copy number variation measurement application to its RainDrop Digital PCR system.

Biotec Pharmacon of Tromsø, Norway, has been awarded US Patent No. 8,551,753, "Method of removing nucleic acid contamination in reverse transcription and amplification reactions."
Olav Lanes, Morten Elde, and Dag Rune Gjellesvik are named as inventors.

BG Medicine this week reported second quarter revenues of $1 million, up 62 percent from $622,000 in the second quarter of 2012.

NEW YORK (GenomeWeb News) – Royalty payments received by BG Medicine from its development and commercialization partners may be reduced following the establishment of a payment rate for the firm's galectin-3 test by the US Centers for Medicare and Medicaid Services, the company said recently in i

Researchers testing a prototype of a Roche next-gen sequencing assay to measure drug resistance in HIV patients recently reported that the test's performance was comparable to Siemen's TruGene assay, which uses real-time PCR and Sanger sequencing and is approved by the US Food an

Pages

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.